Implantica reported a mixed financial performance for Q4 2024, with a 30% year-over-year decrease in quarterly revenue to €442,000, while full-year net sales rose by 38% to €1.9 million. The company's ...
Announces Exit of DNA Tagging and Security Products and Services Business Segment -- Workforce Reduction of 20% of Headcount Implemented in ...
Cellebrite DI (CLBT) reported its fourth-quarter and full-year 2024 earnings, revealing a revenue of $109 million for Q4, surpassing expectations with an EPS of $0.08 against a forecast of $0.06. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results